Authors

• Xiang‐Ping Yang (ORCID: https://orcid.org/0000-0001-9003-1772)
• Yiyu Qian (ORCID: https://orcid.org/0000-0002-3733-320X)
• Yu Xia (ORCID: https://orcid.org/0000-0002-5313-100X)
• Zhiqiang Han
• Qinglei Gao (ORCID: https://orcid.org/0000-0002-9448-3423)
• Emmanuel Kwateng Drokow (ORCID: https://orcid.org/0000-0002-7363-9281)
• Pingfei Li
• Yong Fang
• Zanhong Wang (ORCID: https://orcid.org/0000-0002-1339-4411)
• Wen Pan (ORCID: https://orcid.org/0000-0002-9262-8342)
• Xin Li (ORCID: https://orcid.org/0000-0003-0469-5121)
• Siyuan Wang (ORCID: https://orcid.org/0000-0001-5238-4403)
• Ping Jin (ORCID: https://orcid.org/0009-0006-5774-3421)
• Qi Zhang (ORCID: https://orcid.org/0009-0000-1799-6252)
• Li Xiong (ORCID: https://orcid.org/0000-0002-7459-4070)
• Ning Jin
• Zhengmao Zhang (ORCID: https://orcid.org/0000-0002-3642-3481)
• Pu Huang (ORCID: https://orcid.org/0000-0001-9118-4164)

Institutions

• Hebei Medical University (CN)
• Hubei University of Medicine (CN)
• Central South University (CN)
• Hubei University of Science and Technology (CN)
• Fourth Hospital of Hebei Medical University (CN)
• Shandong Provincial Hospital (CN)
• Shanxi Academy of Medical Sciences (CN)
• Tongji Hospital (CN)
• Shandong First Medical University (CN)
• Huazhong University of Science and Technology (CN)

Publication Details

Journal

Journal for ImmunoTherapy of Cancer

Published

2024-10-01

DOI

https://doi.org/10.1136/jitc-2024-009032

Citations

30

Primary Topic

PARP inhibition in cancer therapy

Type

article

Field-Weighted Citation Impact

8.48